(Q37878160)

English

Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections

scientific article published on May 1999

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

M Dowzicky

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

H Nadler

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

M B Dorr

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

A Acusta

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

G H Talbot

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

790-805; discussion 789

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of sparfloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of sparfloxacin (AT-4140), PD127391 and PD131628 against Legionella spp

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety profile of sparfloxacin, a new fluoroquinolone antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(99)80002-2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37878160&oldid=2224260410"